Skip to main content

Table 3 RA patients association between neuromuscular outcomes and clinical characteristics controlled by physical activity level

From: Quadriceps muscle properties in rheumatoid arthritis: insights about muscle morphology, activation and functional capacity

 

TUG

Torque

VL RMS

Muscle thickness

Pennation Angle

Fascicle Length

Disease duration

r = −0.030

r = 0.180

r = 0.224

r = −0.003

r = −0.310

r = 0.318

p = 0.879

p = 0.328

p = 0.244

p = 0.988

p = 0.102

p = 0.093

DAS28-ESR

r = −0.248

r = 0.161

r = −0.202

r = 0.036

r = −0.126

r = 0.161

p = 0.194

p = 0.404

p = 0.294

p = 0.851

p = 0.515

p = 0.404

HAQ

r = −0.119

r = − 0.017

r = − 0.161

r = − 0.013

r = − 0.081

r = − 0.057

p = 0.539

p = 0.929

p = 0.403

p = 0.948

p = 0.676

p = 0.770

Current dose of GC

r = −0.201

r = 0.069

r = −0.104

r = 0.131

r = 0.092

r = 0.018

p = 0.296

p = 0.721

p = 0.592

p = 0.498

p = 0.634

p = 0.927

Accumulated dose of GC

r = −0.172

r = 0.125

r = −0.030

r = 0.084

r = −0.121

r = 0.164

p = 0.373

p = 0.518

p = 0.877

p = 0.663

p = 0.531

p = 0.395

Pain

r = −0.088

r = 0.076

r = −0.002

r = 0.232

r = 0.128

r = 0.111

p = 0.649

p = 0.697

p = 0.993

p = 0.225

p = 0.509

p = 0.566

  1. DAS28-ESR Disease Activity Score-28 with Erythrocyte Sedimentation Rate, HAQ Health Assessment Questionnaire, GC Glucocorticoids